On July 8, 2024, the U.S. Food and Drug Administration (“FDA”) issued a new draft guidance for industry titled, Addressing Misinformation About Medical Devices and Prescription Drugs – Questions and ...
FDA released a Revised Draft Guidance document with recommended practices for combatting misinformation online. Firms may wish to issue tailored responsive communications to combat specific instances ...
For a long time, brand leadership centered on experience and long-range thinking. Those qualities still matter, but a new expectation has grown in importance. More people now judge leaders by how ...